Antitumorigenic targets of cannabinoids - current status and implications

Area of Science:

• Oncology
• Pharmacology
• Molecular Biology

Background:

• The endocannabinoid system (ECS) is increasingly recognized for its role in cancer.
• Molecular targets within the ECS are being explored for systemic cancer therapy.

Purpose of the Study:

• To review the ECS's contribution to cancer progression.
• To highlight preclinical data on cannabinoid-mediated anti-cancer mechanisms.

Main Methods:

• Literature review of preclinical studies.
• Focus on antimetastatic, anti-invasive, and anti-angiogenic effects of cannabinoids.

Main Results:

• Cannabinoids demonstrate significant antimetastatic properties.
• Evidence suggests cannabinoids inhibit cancer cell invasion and angiogenesis.
• The ECS modulates multiple pathways involved in cancer progression.

Conclusions:

• Targeting the ECS offers a promising strategy for systemic cancer treatment.
• Cannabinoids possess a favorable safety profile.
• Cannabinoid-based drugs could serve as novel 'antimetastatics'.